Pharmabiz

Global regulatory authorities reaffirm labelling as a high-impact tool to combat antimicrobial resistance

Global regulatory authorities reaffirm labelling as a high-impact tool to combat antimicrobial resistance: Geneva Monday, February 2, 2026, 11:00 Hrs [IST] Global regulatory leade ...
Pharmabiz

EMA committee recommends conditional marketing authorization to Sanofi’s Rezurock to treat chronic graft-vs-host disease

EMA committee recommends conditional marketing authorization to Sanofi’s Rezurock to treat chronic graft-vs-host disease: Paris Monday, February 2, 2026, 10:00 Hrs [IST] Sanofi ...
Pharmabiz

LogiPharma event to take place from 14 to 16 April, 2026 at the Austria Center, Vienna

LogiPharma event to take place from 14 to 16 April, 2026 at the Austria Center, Vienna: UK Monday, February 2, 2026, 09:00 Hrs [IST] LogiPharma has launched the agenda for its 202 ...
Pharmabiz

India–EU FTA has the potential to be a game changer for pharma & med-tech: Dr Sujit Paul

Nandita Vijayasimha, Bengaluru Monday, February 2, 2026, 08:00 Hrs [IST] ...
Pharmabiz

India–EU FTA positions Indian pharma & healthcare talent to collaborate across a vast EU market: Dr Abhay Sinha

Shardul Nautiyal, Mumbai Monday, February 2, 2026, 08:00 Hrs [IST] ...
Pharmabiz

Govt proposes amendment of rules to allow drug imports through Navi Mumbai International Airport

Govt proposes amendment of rules to allow drug imports through Navi Mumbai International Airport: Gireesh Babu, New Delhi Monday, February 2, 2026, 08:00 Hrs [IST] The Union minis ...
Pharmabiz

Health ministry proposes multifold increase in testing fees under Schedule B and B1 of Drugs Rules

Gireesh Babu, New Delhi Monday, February 2, 2026, 08:00 Hrs [IST] ...
Pharmabiz

AICDF issues stern warning to Sanofi India over whimsical trade policies

AICDF issues stern warning to Sanofi India over whimsical trade policies: Peethaambaran Kunnathoor, Chennai Monday, February 2, 2026, 08:00 Hrs [IST] The All India Chemists and Di ...
Pharmabiz

Budget proposes Rs. 10,000 crore Biopharma Shakti, exempts BCD for 17 drugs & import duty on 7 more rare diseases

Budget proposes Rs. 10,000 crore Biopharma Shakti, exempts BCD for 17 drugs & import duty on 7 more rare diseases: Our Bureau, New Delhi Sunday, February 1, 2026, 14:15 Hrs [IST] ...